Charles River Laboratories International, Inc. (CRL) shareholders
Close on Nov 17, 2026Market cap $15.86BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| FMR LLC Joint filing with Abigail P. Johnson (12.40%) | 5,922,755 | 12.40% | 13G (passive) amendment | Sep 30, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (10.20%) | 4,865,628 | 10.20% | 13G (passive) amendment | Aug 31, 2026 |
| Vanguard Capital Management | 3,634,376 | 7.38% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 3,524,401 | 6.90% | 13G (passive) amendment | Mar 31, 2025 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (6.50%), Wellington Investment Advisors Holdings LLP (6.50%) and 1 more | 3,190,467 | 6.50% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CRL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 4,239,752 | 8.88% | $961.53M | +783,508 | 0.04% |
| BlackRock, Inc. | 3,798,560 | 7.96% | $861.48M | −60,540 | 0.01% |
| Vanguard Capital Management LLC | 3,149,288 | 6.60% | $714.23M | −52,916 | 0.02% |
| Invesco Ltd. | 2,984,785 | 6.25% | $676.92M | +587,533 | 0.05% |
| Harris Associates L P | 2,241,144 | 4.69% | $508.27M | +87,848 | 0.67% |
| Vanguard Portfolio Management LLC | 2,210,979 | 4.63% | $501.43M | −83,691 | 0.02% |
| Allspring Global Investments Holdings, LLC | 1,905,247 | 3.99% | $436.47M | −88,069 | 0.67% |
| State Street Corp | 1,864,284 | 3.91% | $422.80M | −9,334 | 0.01% |
| Dimensional Fund Advisors LP | 1,648,450 | 3.45% | $373.85M | −4,034 | 0.07% |
| Ariel Investments, LLC | 1,506,185 | 3.16% | $341.59M | +62,002 | 3.41% |
| Price T Rowe Associates Inc /Md/ | 1,505,370 | 3.15% | $341.40M | +380,227 | 0.03% |
| Geode Capital Management, LLC | 1,305,738 | 2.74% | $295.60M | +44 | 0.02% |
| Wellington Management Group Llp | 1,288,463 | 2.70% | $292.21M | −340,938 | 0.05% |
| Citadel Advisors LLC | 1,193,601 | 2.50% | $270.70M | −18,551 | 0.03% |
| Bank Of America Corp /De/ | 1,172,586 | 2.46% | $265.93M | +37,559 | 0.02% |
| Earnest Partners LLC | 1,120,011 | 2.35% | $254.01M | +148,645 | 0.92% |
| Ameriprise Financial Inc | 881,189 | 1.85% | $199.83M | −228,198 | 0.04% |
| Neuberger Berman Group LLC | 862,704 | 1.81% | $195.63M | −11,674 | 0.13% |
| Sei Investments Co | 813,530 | 1.70% | $184.50M | +56,401 | 0.16% |
| Morgan Stanley | 800,487 | 1.68% | $181.54M | −25,181 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 569 | 57M | 100.0% | 78 / 195 | 202 / 62 | 5M | 6M |
| Q1 2026 | 561 | 58M | 100.0% | 74 / 190 | 200 / 87 | 15M | 5M |
| Q4 2025 | 583 | 53M | 100.0% | 117 / 179 | 205 / 81 | 11M | 8M |
| Q3 2025 | 556 | 51M | 100.0% | 99 / 191 | 189 / 56 | 7M | 7M |
| Q2 2025 | 519 | 51M | 100.0% | 92 / 173 | 201 / 128 | 12M | 14M |
| Q1 2025 | 562 | 53M | 100.0% | 68 / 187 | 244 / 131 | 8M | 10M |
| Q4 2024 | 636 | 55M | 100.0% | 100 / 178 | 281 / 83 | 8M | 6M |
| Q3 2024 | 629 | 53M | 100.0% | 68 / 204 | 272 / 97 | 12M | 7M |
| Q2 2024 | 665 | 53M | 100.0% | 74 / 263 | 238 / 79 | 4M | 4M |
| Q1 2024 | 675 | 54M | 100.0% | 92 / 257 | 228 / 48 | 5M | 4M |
| Q4 2023 | 634 | 53M | 100.0% | 94 / 203 | 259 / 70 | 4M | 3M |
| Q3 2023 | 622 | 52M | 100.0% | 80 / 230 | 219 / 62 | 4M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
583 funds held CRL in Q2 2026, 35% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CRL | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Contrafund | 1,807,861 | 3.79% | $410.00M | 0.23% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,530,171 | 3.21% | $347.03M | 0.02% | Jun 30, 2026 |
| Oakmark Select Fund | 1,498,000 | 3.14% | $339.73M | 4.08% | Jun 30, 2026 |
| Allspring Special Mid Cap Value Fund | 1,453,264 | 3.04% | $329.59M | 2.45% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 1,247,732 | 2.61% | $282.97M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,104,850 | 2.31% | $250.57M | 0.13% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 1,001,035 | 2.10% | $232.75M | 0.24% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 699,768 | 1.47% | $158.70M | 0.23% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 662,569 | 1.39% | $150.26M | 0.02% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 629,807 | 1.32% | $113.81M | 0.01% | May 31, 2026 |
| Invesco Small Cap Value Fund | 627,460 | 1.31% | $145.89M | 1.31% | Jul 31, 2026 |
| Ariel Fund | 557,758 | 1.17% | $126.49M | 4.37% | Jun 30, 2026 |
| Invesco Value Opportunities Fund | 472,534 | 0.99% | $109.87M | 1.21% | Jul 31, 2026 |
| Vanguard Selected Value Fund | 399,160 | 0.84% | $92.81M | 1.33% | Jul 31, 2026 |
| Fidelity Contrafund K6 | 387,614 | 0.81% | $87.91M | 0.23% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Birgit Girshick | Chief Executive Officer, Director | 79,288 | 0.17% | Aug 20, 2026 |
| Michael Gunnar Knell | SVP, Finance and CAO | 11,203 | 0.02% | Nov 9, 2026 |
| Shannon M. Parisotto | CEVP, Disc & Safety Assessment | 42,997 | 0.09% | Oct 23, 2026 |
| Glenn Coleman | EVP & Chief Financial Officer | 27,762 | 0.06% | Oct 2, 2026 |
| Joseph W. LaPlume | EVP, Corp Strategy & Develop | 31,041 | 0.07% | Aug 11, 2026 |
| Victoria L. Creamer | EVP & Chief People Officer | 34,230 | 0.07% | Aug 10, 2026 |
| Mark Mintz | EVP, Chief Information Officer | 9,546 | 0.02% | Jun 2, 2026 |
| Flavia Pease | Corporate Executive VP & CFO | 17,297 | 0.04% | Jun 3, 2025 |
| James C. Foster | Director | 233,410 | 0.49% | Oct 26, 2026 |
| Nancy C. Andrews | Director | 5,402 | 0.01% | Aug 20, 2026 |
| Steven Barg | Director | 3,287 | 0.01% | Jun 3, 2026 |
| Paul W. Graves | Director | 2,384 | 0.00% | May 12, 2026 |
| Craig B. Thompson | Director | 3,851 | 0.01% | May 12, 2026 |
| Martin Mackay | Director | 17,137 | 0.04% | May 11, 2026 |
| Virginia M. Wilson | Director | 6,349 | 0.01% | May 11, 2026 |
| Abraham Ceesay | Director | 2,384 | 0.00% | May 11, 2026 |
| Mark J. Enyedy | Director | 2,384 | 0.00% | May 11, 2026 |
| George Llado Sr. | Director | 6,702 | 0.01% | May 11, 2026 |
| Reshema Kemps-Polanco | Director | 4,563 | 0.01% | May 11, 2026 |
| George Massaro | Director | 5,575 | 0.01% | May 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael Gunnar Knell SVP, Finance and CAO | Nov 6, 2026 | Tax withholding | −649 | $313.02 | $203.15K | 11,203 |
| James C. Foster Director | Oct 22, 2026 | Sale(10b5-1 plan) | −24,042 | $350.00 | $8.41M | 31,596 |
| James C. Foster Director | Oct 22, 2026 | Option exercise | +24,042 | $244.41 | $5.88M | 55,638 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Oct 21, 2026 | Sale(10b5-1 plan) | −2,156 | $344.41 | $742.55K | 4,807 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Oct 21, 2026 | Option exercise | +2,156 | $244.41 | $526.95K | 6,963 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Oct 5, 2026 | Sale(10b5-1 plan) | −981 | $308.44 | $302.58K | 4,807 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Oct 5, 2026 | Option exercise | +981 | $208.44 | $204.48K | 5,788 |
| Glenn Coleman EVP & Chief Financial Officer | Sep 30, 2026 | Buy | +10 | $297.43 | $2.97K | 27,762 |
| James C. Foster Director | Aug 25, 2026 | Sale(10b5-1 plan) | −33,561 | $300.00 | $10.07M | 31,596 |
| James C. Foster Director | Aug 25, 2026 | Option exercise | +21,132 | $194.12 | $4.10M | 52,728 |
| James C. Foster Director | Aug 25, 2026 | Option exercise | +12,429 | $208.44 | $2.59M | 65,157 |
| Birgit Girshick Chief Executive Officer, Director | Aug 19, 2026 | Gift | −528 | – | – | 35,485 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Aug 19, 2026 | Option exercise | +2,039 | $194.12 | $395.81K | 6,846 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Aug 19, 2026 | Sale(10b5-1 plan) | −2,039 | $294.12 | $599.71K | 4,807 |
| Nancy C. Andrews Director | Aug 18, 2026 | Sale | −573 | $285.24 | $163.44K | 1,438 |
| Nancy C. Andrews Director | Aug 18, 2026 | Option exercise | +573 | $164.30 | $94.14K | 2,011 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Aug 11, 2026 | Option exercise | +3,714 | $179.66 | $667.26K | 8,521 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Aug 11, 2026 | Sale(10b5-1 plan) | −3,714 | $279.66 | $1.04M | 4,807 |
| Birgit Girshick Chief Executive Officer, Director | Aug 11, 2026 | Option exercise | +6,500 | $179.66 | $1.17M | 42,513 |
| Birgit Girshick Chief Executive Officer, Director | Aug 11, 2026 | Sale(10b5-1 plan) | −6,500 | $279.90 | $1.82M | 36,013 |
| Joseph W. LaPlume EVP, Corp Strategy & Develop | Aug 10, 2026 | Gift | −257 | – | – | 31,041 |
| James C. Foster Director | Aug 10, 2026 | Sale(10b5-1 plan) | −28,733 | $275.00 | $7.90M | 31,596 |
| James C. Foster Director | Aug 10, 2026 | Option exercise | +28,733 | $179.66 | $5.16M | 60,329 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −482 | $265.17 | $127.81K | 11,852 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −1,205 | $258.53 | $311.53K | 12,588 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −404 | $258.53 | $104.45K | 13,793 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Option exercise | +736 | $208.44 | $153.41K | 14,197 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Option exercise | +1,205 | $194.12 | $233.91K | 13,461 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Option exercise | +404 | $179.66 | $72.58K | 12,256 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −736 | $258.53 | $190.28K | 11,852 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −620 | $263.94 | $163.64K | 12,334 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −213 | $262.37 | $55.88K | 12,954 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −810 | $261.45 | $211.77K | 13,167 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −901 | $260.63 | $234.83K | 13,977 |
| Michael Gunnar Knell SVP, Finance and CAO | Aug 6, 2026 | Sale | −1,274 | $259.07 | $330.06K | 14,878 |
| Victoria L. Creamer EVP & Chief People Officer | Aug 6, 2026 | Option exercise | +4,179 | $179.66 | $750.80K | 34,230 |
| Victoria L. Creamer EVP & Chief People Officer | Aug 6, 2026 | Sale | −4,179 | $259.16 | $1.08M | 30,051 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Aug 5, 2026 | Sale(10b5-1 plan) | −5,046 | $263.00 | $1.33M | 4,807 |
| James C. Foster Director | Jun 29, 2026 | Sale(10b5-1 plan) | −75,000 | $225.00 | $16.88M | 31,596 |
| James C. Foster Director | Jun 5, 2026 | Gift | +153,361 | – | – | 155,611 |
| James C. Foster Director | Jun 5, 2026 | Gift | −20,000 | – | – | 106,596 |
| James C. Foster Director | Jun 5, 2026 | Gift | +20,000 | – | – | 20,000 |
| James C. Foster Director | Jun 5, 2026 | Gift | −10,000 | – | – | 0 |
| James C. Foster Director | Jun 5, 2026 | Gift | +10,000 | – | – | 10,000 |
| James C. Foster Director | Jun 5, 2026 | Gift | −153,361 | – | – | 126,596 |
| Birgit Girshick Chief Executive Officer | Jun 5, 2026 | Gift | +3,386 | – | – | 43,803 |
| Birgit Girshick Chief Executive Officer | Jun 5, 2026 | Gift | −3,386 | – | – | 36,013 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Jun 5, 2026 | Gift | +1,529 | – | – | 9,680 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | Jun 5, 2026 | Gift | −1,529 | – | – | 9,853 |
| Steven Barg Director | Jun 2, 2026 | Award | +422 | $174.79 | $73.76K | 3,287 |
| Joseph W. LaPlume EVP, Corp Strategy & Develop | May 31, 2026 | Tax withholding | −235 | $180.71 | $42.47K | 31,298 |
| Birgit Girshick Chief Executive Officer | May 31, 2026 | Tax withholding | −378 | $180.71 | $68.31K | 39,399 |
| Mark Mintz EVP, Chief Information Officer | May 31, 2026 | Tax withholding | −64 | $180.71 | $11.57K | 9,546 |
| Shannon M. Parisotto CEVP, Disc & Safety Assessment | May 31, 2026 | Tax withholding | −170 | $180.71 | $30.72K | 11,382 |
| Victoria L. Creamer EVP & Chief People Officer | May 31, 2026 | Tax withholding | −194 | $180.71 | $35.06K | 30,051 |
| Michael Gunnar Knell SVP, Finance and CAO | May 31, 2026 | Tax withholding | −48 | $180.71 | $8.67K | 16,152 |
| Joseph W. LaPlume EVP, Corp Strategy & Develop | May 30, 2026 | Tax withholding | −744 | $180.71 | $134.45K | 31,533 |
| Birgit Girshick Chief Executive Officer | May 30, 2026 | Tax withholding | −1,204 | $180.71 | $217.57K | 39,777 |
| James C. Foster Director | May 30, 2026 | Tax withholding | −1,596 | $180.71 | $288.41K | 279,957 |
| Mark Mintz EVP, Chief Information Officer | May 30, 2026 | Tax withholding | −305 | $180.71 | $55.12K | 9,610 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Charles River Laboratories International's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,984 shares on Aug 26, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| James C. Foster Director | Oct 22, 2026 | 24,042 | $8.41M | Oct 22, 2026 | Exercise of stock options |
| Shannon M. Parisotto Officer | Oct 21, 2026 | 2,156 | $742.55K | Oct 21, 2026 | Exercise of Stock Options |
| Shannon M. Parisotto Officer | Oct 5, 2026 | 981 | $308.58K | Oct 5, 2026 | Exercise of Stock Options |
| James C. Foster Director | Aug 25, 2026 | 33,561 | $10.07M | Aug 25, 2026 | Exercise of stock options |
| Shannon M. Parisotto Officer | Aug 19, 2026 | 2,039 | $599.71K | Aug 19, 2026 | Exercise of Stock Options |
| Nancy C. Andrews Director | Aug 18, 2026 | 573 | $163.31K | Aug 18, 2026 | Stock Option Exercise |
| Birgit Girshick Officer, CEO & President | Aug 11, 2026 | 6,500 | $1.82M | Aug 11, 2026 | Exercise of Stock Options |
| Shannon M. Parisotto Officer | Aug 11, 2026 | 3,714 | $1.04M | Aug 11, 2026 | Exercise of Stock Options |
| James C. Foster Director | Aug 10, 2026 | 28,733 | $7.90M | Aug 10, 2026 | Exercise of stock options |
| Victoria L. Creamer Officer | Aug 6, 2026 | 4,179 | $1.09M | Aug 6, 2026 | Stock Option Exercise |
| Michael Gunnar Knell Officer | Aug 6, 2026 | 6,645 | $1.73M | Aug 6, 2026 | RSUs & PSUs |
| Shannon M. Parisotto Officer | Aug 5, 2026 | 5,046 | $1.33M | Aug 5, 2026 | Performance Stock Award |
| James C. Foster Director | Jun 29, 2026 | 75,000 | $16.88M | Jun 29, 2026 | RSU/PSU |
| Joseph W. LaPlume Officer | Aug 22, 2025 | 400 | $61.00K | Aug 22, 2025 | Performance Stock Unit |
| Joseph W. LaPlume Officer | Aug 18, 2025 | 800 | $125.60K | Aug 18, 2025 | PERFORMANCE STOCK UNIT |
Congress trades
9 trades in Charles River Laboratories International reported by 6 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Rob Bresnahan PA08 | Sold | May 15, 2025 | $1K–15K | May 31, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Jefferson Shreve IN06 | Bought | May 8, 2025 | $15K–50K | Jun 22, 2025 |
| Rob Bresnahan PA08 | Bought | Apr 8, 2025 | $15K–50K | May 8, 2025 |
| Julie Johnson TX32 · joint account | Bought | Jan 15, 2025 | $1K–15K | Feb 12, 2025 |
| Lois Frankel FL22 | Sold | Sep 8, 2023 | $1K–15K | Oct 10, 2023 |
| Lois Frankel FL22 | Bought | Apr 25, 2023 | $1K–15K | May 19, 2023 |
| Zoe Lofgren CA18 · spouse | Sold | Aug 25, 2022 | $1K–15K | Sep 13, 2022 |
| Lamar Smith TX21 | Bought | Feb 13, 2018 | $1K–15K | Mar 7, 2018 |
See a number that looks wrong?